Skip to main content
Signal8

Wessel Tadd S.

SEC insider (Form 3/4/5 filer). CIK 0002048706. Director at PALVELLA THERAPEUTICS, INC. (PVLA). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in WAYNE, PA.

Companies Wessel Tadd S. has filed insider reports for

  • PALVELLA THERAPEUTICS, INC. (PVLA): Director
Wessel Tadd S. profile photo

Wessel Tadd S.

CIK: 0002048706

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PALVELLA THERAPEUTICS, INC. logo
PVLA

PALVELLA THERAPEUTICS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • PALVELLA THERAPEUTICS, INC. logo
    PVLA

    PALVELLA THERAPEUTICS, INC.

    Jun 10, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    3K shares-
  • PALVELLA THERAPEUTICS, INC. logo
    PVLA

    PALVELLA THERAPEUTICS, INC.

    Jun 10, 2025
    Award

    Non-Qualified Stock Option (right to buy)

    Direct
    12.4K shares-
  • PALVELLA THERAPEUTICS, INC. logo
    PVLA

    PALVELLA THERAPEUTICS, INC.

    Dec 13, 2024
    Award

    Stock Option (right to buy)

    Direct
    24.7K shares-

1-3 of 3